Winning in Pharmaceutical Emerging Markets with Analytics
With the high costs of developing a new drug, mature pharma markets are stagnating. It is important for these companies to recognize the importance of emerging markets. Over the next five years, over two-thirds of pharmaceutical sales growth will come from emerging markets. There is enormous potential there, and there is a way for a company to gain a competitive advantage by using big data. Analytics can help a company figure out who needs what drugs, and where, for the right prices.
To learn more about how big data can help a company gain a competitive edge, check out the infographic below, presented by Spotfire.